https://www.selleckchem.com/pr....oducts/LY2603618-IC-
Viral infections cause life-threatening diseases in millions of people worldwide every year and there is urgent need for new effective antiviral drugs. Hybridization of two chemically diverse compounds into a new bioactive effector product is a successful concept to improve the hybrid drug's properties compared to its parent compounds. In this study, (iso)quinoline-artemisinin hybrids, obtained via copper-catalyzed azide-alkyne cycloaddition (CuAAC) or organocatalyzed click reactions (in organic solvents or in the presence of wa
Curtir
Comentario
Compartilhar
